Literature DB >> 12835244

Institutionalisation and schizophrenia in Japan: social environments and negative symptoms: Nationwide survey of in-patients.

Iwao Oshima1, Yoshio Mino, Yoshimasa Inomata.   

Abstract

BACKGROUND: The number of psychiatric beds per capita in Japan is the highest in the world, and a replication of earlier British research is needed to identify possible means of improving the mental health system. Aims To describe the current situation of psychiatric hospitals in Japan and to examine the relationship between negative symptoms of schizophrenia and social environments.
METHOD: In-patients with schizophrenia were randomly selected from 139 hospitals. Data were obtained for 2758 participants using several scales, including the Manchester Scale and social environment scales.
RESULTS: Negative symptom scales showed a significant correlation with understimulating social environments in hospitals.
CONCLUSIONS: This study confirms the results from the UK and provides evidence for the importance of community-based care and for providing more-stimulating rehabilitation environments.

Entities:  

Mesh:

Year:  2003        PMID: 12835244     DOI: 10.1192/bjp.183.1.50

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  17 in total

1.  Relationship between whether the planned discharge destination is decided and locomotive syndrome for admitted patients in psychiatric long-term care wards.

Authors:  Munetsugu Kota; Sae Uezono; Yusuke Ishibashi; Sousuke Kitakaze; Hideki Arakawa
Journal:  Phys Ther Res       Date:  2020-08-20

2.  Evaluating the WHO Assessment Instrument for Mental Health Systems by comparing mental health policies in four countries.

Authors:  Hamada Hamid; Karen Abanilla; Besa Bauta; Keng-Yen Huang
Journal:  Bull World Health Organ       Date:  2008-06       Impact factor: 9.408

3.  Psychiatrist characteristics related to patient outcome in Japan.

Authors:  Takeru Abe; Megumi Moriya; Koji Ikeda; Kenji Kuroda; Akihito Hagihara
Journal:  Psychiatr Q       Date:  2012-06

Review 4.  Research strategies and priorities to improve the lives of people with schizophrenia: executive summary of the Ernst Strüngmann Forum on schizophrenia.

Authors:  Steven M Silverstein; Bita Moghaddam; Til Wykes
Journal:  Schizophr Bull       Date:  2014-01-28       Impact factor: 9.306

5.  Barriers to mental health care in Japan: Results from the World Mental Health Japan Survey.

Authors:  Akiko Kanehara; Maki Umeda; Norito Kawakami
Journal:  Psychiatry Clin Neurosci       Date:  2015-02-09       Impact factor: 5.188

Review 6.  The Societal Cost of Schizophrenia: A Systematic Review.

Authors:  Huajie Jin; Iris Mosweu
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

7.  Outcomes of Physiotherapy on Activities of Daily Living and Discharge to the Community in Psychiatric Long-term Care Ward Patients.

Authors:  Munetsugu Kota; Sae Uezono; Yusuke Ishibashi; Shouichi Kuramochi; Sousuke Kitakaze; Seiji Kaganoi
Journal:  Phys Ther Res       Date:  2022-05-13

8.  Application of Level of Care Utilization System for Psychiatric and Addiction Services (LOCUS) to psychiatric practice in Japan: a preliminary assessment of validity and sensitivity to change.

Authors:  Taku Kimura; Fukashi Yagi; Akira Yoshizumi
Journal:  Community Ment Health J       Date:  2012-11-29

9.  A cluster randomised controlled trial of a staff-training intervention in residential units for people with long-term mental illness in Portugal: the PromQual trial.

Authors:  Graça Cardoso; Ana Papoila; Gina Tomé; Helen Killaspy; Michael King; José Miguel Caldas-de-Almeida
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-06-30       Impact factor: 4.328

10.  The quality of life among persons with severe mental illness enrolled in an assertive community treatment program in Japan: 1-year follow-up and analyses.

Authors:  Masaaki Nisihio; Iwao Oshima; Junichiro Ito; Hiroo Matsuoka; Kazumi Tsukada; Kentaro Horiuchi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.